Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer's disease pathogenesis
(2023) In Acta Neuropathologica Communications 11.- Abstract
The hippocampus is a primary region affected in Alzheimer's disease (AD). Because AD postmortem brain tissue is not available prior to symptomatic stage, we lack understanding of early cellular pathogenic mechanisms. To address this issue, we examined the cellular origin and progression of AD pathogenesis by comparing patient-based model systems including iPSC-derived brain cells transplanted into the mouse brain hippocampus. Proteomic analysis of the graft enabled the identification of pathways and network dysfunction in AD patient brain cells, associated with increased levels of Aβ-42 and β-sheet structures. Interestingly, the host cells surrounding the AD graft also presented alterations in cellular biological pathways. Furthermore,... (More)
The hippocampus is a primary region affected in Alzheimer's disease (AD). Because AD postmortem brain tissue is not available prior to symptomatic stage, we lack understanding of early cellular pathogenic mechanisms. To address this issue, we examined the cellular origin and progression of AD pathogenesis by comparing patient-based model systems including iPSC-derived brain cells transplanted into the mouse brain hippocampus. Proteomic analysis of the graft enabled the identification of pathways and network dysfunction in AD patient brain cells, associated with increased levels of Aβ-42 and β-sheet structures. Interestingly, the host cells surrounding the AD graft also presented alterations in cellular biological pathways. Furthermore, proteomic analysis across human iPSC-based models and human post-mortem hippocampal tissue projected coherent longitudinal cellular changes indicative of early to end stage AD cellular pathogenesis. Our data showcase patient-based models to study the cell autonomous origin and progression of AD pathogenesis.
(Less)
- author
- organization
-
- StemTherapy: National Initiative on Stem Cells for Regenerative Therapy
- MultiPark: Multidisciplinary research focused on Parkinson´s disease
- IPSC Laboratory for CNS Disease Modeling (research group)
- Stem Cell Center
- Clinical Protein Science and Imaging (research group)
- LU Profile Area: Light and Materials
- LU Profile Area: Proactive Ageing
- LTH Profile Area: Nanoscience and Semiconductor Technology
- LINXS - Institute of advanced Neutron and X-ray Science
- NanoLund: Centre for Nanoscience
- Medical Microspectroscopy (research group)
- Lund University Bioimaging Center
- WCMM-Wallenberg Centre for Molecular Medicine
- eSSENCE: The e-Science Collaboration
- Lung Biology (research group)
- Experimental Dementia Research (research group)
- Mass Spectrometry
- BioMS (research group)
- Department of Biomedical Engineering
- publishing date
- 2023-09-15
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Animals, Mice, Humans, Alzheimer Disease, Induced Pluripotent Stem Cells, Proteomics, Autopsy, Hippocampus
- in
- Acta Neuropathologica Communications
- volume
- 11
- article number
- 150
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:37715247
- scopus:85171384157
- ISSN
- 2051-5960
- DOI
- 10.1186/s40478-023-01649-z
- language
- English
- LU publication?
- yes
- additional info
- © 2023. BioMed Central Ltd., part of Springer Nature.
- id
- 652ae1e0-7bc4-4bfa-8109-3292ab279715
- date added to LUP
- 2023-09-23 20:01:02
- date last changed
- 2024-11-30 01:16:26
@article{652ae1e0-7bc4-4bfa-8109-3292ab279715, abstract = {{<p>The hippocampus is a primary region affected in Alzheimer's disease (AD). Because AD postmortem brain tissue is not available prior to symptomatic stage, we lack understanding of early cellular pathogenic mechanisms. To address this issue, we examined the cellular origin and progression of AD pathogenesis by comparing patient-based model systems including iPSC-derived brain cells transplanted into the mouse brain hippocampus. Proteomic analysis of the graft enabled the identification of pathways and network dysfunction in AD patient brain cells, associated with increased levels of Aβ-42 and β-sheet structures. Interestingly, the host cells surrounding the AD graft also presented alterations in cellular biological pathways. Furthermore, proteomic analysis across human iPSC-based models and human post-mortem hippocampal tissue projected coherent longitudinal cellular changes indicative of early to end stage AD cellular pathogenesis. Our data showcase patient-based models to study the cell autonomous origin and progression of AD pathogenesis.</p>}}, author = {{Pomeshchik, Yuriy and Velasquez, Erika and Gil, Jeovanis and Klementieva, Oxana and Gidlöf, Ritha and Sydoff, Marie and Bagnoli, Silvia and Nacmias, Benedetta and Sorbi, Sandro and Westergren-Thorsson, Gunilla and Gouras, Gunnar K and Rezeli, Melinda and Roybon, Laurent}}, issn = {{2051-5960}}, keywords = {{Animals; Mice; Humans; Alzheimer Disease; Induced Pluripotent Stem Cells; Proteomics; Autopsy; Hippocampus}}, language = {{eng}}, month = {{09}}, publisher = {{BioMed Central (BMC)}}, series = {{Acta Neuropathologica Communications}}, title = {{Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer's disease pathogenesis}}, url = {{http://dx.doi.org/10.1186/s40478-023-01649-z}}, doi = {{10.1186/s40478-023-01649-z}}, volume = {{11}}, year = {{2023}}, }